2Gensini GG.A more meaningful scoring system for determining theseverity of coronary heart disease[J].Am J Cardiol,1983,51(3):606.
3李健斋,魏明竟.现代临床生化检验学[M].北京:人民军医出版社,2007:29-34.
4Anderson TJ,Uehata A,Gerhard MD,et al.Close relation of endo-thelial function in the human coronary and peripheral circulations[J].J Am Coll Cardiol,2010,26(5):1235-1241.
5Zubair AA,Abdul KN,Maujid MM,et al.Microalbuminuria in an-giographically documented coronary heart disease in non diabeticand normotensive individuals[J].Annals King Edward MedicalUniversity,2009,15(3):113-116.
6Klausen KP,Scharling H,Jensen G,et al.New definit of mi-croalbuminuria in hypertensive subjects:Association with incidentcoronary heart disease and death[J].Hypertension,2005,46(1):33-37.
7Freij G,Abhishek D,Sudhir S,et al.Triad of matabolic syndrome,chronic kidney disease,and coronary heart disease with a focus onmicroalbuminuria[J].J Am Coll Cardiol,2011,57:2303-2308.
8Klausen K,Borch-Johnsen K,Feldt-Rasmussen B,et al.Very lowlevels of microalbuminuria are associated with increased risk ofcoronary heart disease and death independently of renal function,hypertension,and diabetes[J].Circulation,2004,110(1):32-35.
9Hoseini VN,Rasouli M.Microalbuminuria correlates with theprevalence and severity of coronary artery disease in non-dia-betic patients[J].Cardiol J,2009,16(2):142-145.
10Spanaus KS, Barbara K, Eberhard R, et al. Serumcreatinine,cystatin C,and beta-trace protein in diag-nostic staging and predicting progression of primary non-diabetic chronic kidney diseasefj]. Clinical Chemistry,2010,56(5) 740-749.
